Rohin Mhatre
Direktor/Vorstandsmitglied bei REPLIGEN CORPORATION
Vermögen: 504 600 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Rohin Mhatre
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
276
| Public Company | Pharmaceuticals: Major | 276 |
Public Company | Pharmaceuticals: Major | 29 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rohin Mhatre
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer Director/Board Member Director of Finance/CFO Chief Operating Officer Director of Finance/CFO Chief Executive Officer | |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Sales & Marketing | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Human Resources Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
University of Massachusetts | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Sales & Marketing Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree Graduate Degree | |
THERMO FISHER SCIENTIFIC | Medical Specialties | Director of Finance/CFO Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Bentley University | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman General Counsel Investor Relations Contact | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member President Director/Board Member Corporate Officer/Principal | |
BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal Public Communications Contact | |
REVVITY, INC. | Medical Specialties | Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member | |
BIOVERATIV INC | Biotechnology | Chairman Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Rensselaer Polytechnic Institute | College/University | Undergraduate Degree Graduate Degree Masters Business Admin | |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
University of California, Berkeley | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
HOLOGIC, INC. | Medical Specialties | Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
SANOFI | Biotechnology | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Biomedical Sciences Careers Program, Inc. | Director/Board Member Corporate Officer/Principal Director/Board Member | ||
UNITY BIOTECHNOLOGY, INC. | Biotechnology | Comptroller/Controller/Auditor Director of Finance/CFO Director/Board Member | |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chairman Founder Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
EDITAS MEDICINE, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Vicarius Pharma AG provides research and development services for pharmaceutical, biotech, and medical companies. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans-Peter Hasler. | Miscellaneous Commercial Services | Chairman Founder Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Operating Officer | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
Yale University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
VERASTEM, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
EXELIXIS, INC. | Pharmaceuticals: Major | Chief Executive Officer Founder Director/Board Member | |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Founder Corporate Officer/Principal | |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer | |
Fondation Santé | Director/Board Member Founder | ||
Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Human Resources Officer Public Communications Contact | |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Samsung Bioepis Co., Ltd.
Samsung Bioepis Co., Ltd. Pharmaceuticals: MajorHealth Technology Samsung Bioepis Co., Ltd. manufactures biopharmaceutical products. The company was founded on February 28, 2012 and is headquartered in Incheon, South Korea. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
Vereinigte Staaten | 44 |
Deutschland | 2 |
Vereinigtes Königreich | 2 |
Frankreich | 2 |
Schweiz | 2 |
Sektoral
Health Technology | 33 |
Consumer Services | 12 |
Finance | 3 |
Commercial Services | 3 |
Consumer Durables | 2 |
Operativ
Director/Board Member | 584 |
Corporate Officer/Principal | 219 |
Independent Dir/Board Member | 172 |
Chairman | 114 |
Chief Executive Officer | 87 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
William Hawkins | 49 |
Christopher Viehbacher | 37 |
Eric Rowinsky | 36 |
William Jones | 33 |
George Scangos | 33 |
William Young | 32 |
Martin Madaus | 30 |
Edward Hu | 29 |
Hans-Peter Hasler | 28 |
Caroline Dorsa | 27 |
Robert W. Pangia | 26 |
Stephen Sherwin | 26 |
Stelios Papadopoulos | 26 |
James Tobin | 26 |
Alexander Denner | 25 |
- Börse
- Insiders
- Rohin Mhatre
- Unternehmensverbindungen